APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 139 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $430,000 | -21.7% | 6,800 | -46.9% | 0.02% | -25.0% |
| Q1 2021 | $549,000 | -31.5% | 12,800 | -8.6% | 0.02% | -45.9% |
| Q4 2020 | $801,000 | +57.1% | 14,000 | -17.2% | 0.04% | +42.3% |
| Q3 2020 | $510,000 | -7.6% | 16,900 | 0.0% | 0.03% | -16.1% |
| Q2 2020 | $552,000 | +73.0% | 16,900 | +42.0% | 0.03% | +34.8% |
| Q1 2020 | $319,000 | -5.3% | 11,900 | +8.2% | 0.02% | +21.1% |
| Q4 2019 | $337,000 | -6.6% | 11,000 | -26.7% | 0.02% | -13.6% |
| Q3 2019 | $361,000 | -5.0% | 15,000 | 0.0% | 0.02% | -4.3% |
| Q2 2019 | $380,000 | +49.6% | 15,000 | +15.4% | 0.02% | +43.8% |
| Q1 2019 | $254,000 | – | 13,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |